Antibodies for treatment of Clostridium difficile infection. - Wikidata - awgldk - TriplyDB

Antibodies for treatment of Clostridium difficile infection.

Antibodies for treatment of Clostridium difficile infection.

http://www.wikidata.org/entity/Q38208794

about

An update on antibody-based immunotherapies for Clostridium difficile infection Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region.A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors.Breakthroughs in the treatment and prevention of Clostridium difficile infection.A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile Novel therapeutic strategies for Clostridium difficile infections.Broadly neutralizing antibodies: An approach to control HIV-1 infection.Management of candidemia in patients with Clostridium difficile infection.Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection.Bezlotoxumab.

P2860

Q26740788-6E7CDDD1-0CC3-482B-B59E-00A1C1642BC8 Q28547242-561CF8C4-A04A-410A-9F02-7CFB4B1539EA Q35172641-22EEA509-9F67-496D-B235-9E8C74995427 Q35332572-244BF044-5C19-468A-9C0F-F37950DD94CB Q35918566-0A42AD9E-FC50-4C78-BD82-A3612E6257F6 Q36172091-05D67FAC-DB4C-48DE-B788-583A3B93ABD3 Q38632664-A28ECBE6-0534-4D27-B209-0133DC3090F5 Q38811735-658EDD47-52CE-4597-9151-43C890A79289 Q38851595-7B12DC9D-B183-4E3B-9BB5-29894E8523C9 Q41990887-C09EE81C-0D15-468E-95F9-47863C2B217B Q49201152-9A63F934-1C61-4ADF-A0B7-3DAC9F879E04 Q53762105-5CCB6978-962F-41E8-B3B1-9894A18CD7E5

P2860

Antibodies for treatment of Clostridium difficile infection.

http://www.wikidata.org/entity/Q38208794

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antibodies for treatment of Clostridium difficile infection.

@en

type

label

Antibodies for treatment of Clostridium difficile infection.

@en

prefLabel

Antibodies for treatment of Clostridium difficile infection.

@en

P1433

Q38208794-48287182-DDF9-4B60-BE22-6C46BCB3A9AC

P1476

Q38208794-02D0496E-2821-4972-B253-37A394DFBE4C

P2093

Q38208794-9B59A829-711A-4417-B878-79BD5835C0AF

P2860

Q38208794-08B39AB3-56C9-463F-8973-74C8F6467A22

Q38208794-0C52F531-42B0-45A2-A51C-9D8C927A04FE

Q38208794-0D7687D1-D8F9-4EE2-A34F-70A57D8C2338

Q38208794-0F078341-2CD1-42C0-9B17-AD3329CB8606

Q38208794-14C57DCC-2390-4EB5-AF90-2F1296EBCD5F

Q38208794-17908650-39F4-4C95-9411-DD1E8CF90473

Q38208794-17B0EB43-5BF9-4367-90DE-BE9BD7B48AD6

Q38208794-19063582-DBD2-4D1A-85E4-BA29A7BB9EA0

Q38208794-198CD01F-76E5-4FB5-842B-4BD2668926E4

Q38208794-1ADD9DB6-EF61-4743-993E-23992E35FA36

P304

Q38208794-34A61A0B-299D-41F1-920E-F77EFF79BB91

P31

Q38208794-CFC20C04-0E43-4348-83E0-B1F3F62E3265

P356

Q38208794-2936A603-2ACC-4D5E-AA6E-444CFE755148

P433

Q38208794-5A857053-D73F-419E-B01F-C322EE6E0FC1

P478

Q38208794-AF87064E-1A0D-4F08-BF91-1A2DEF5B2416

P50

Q38208794-545125DE-5CFA-4FB1-9E92-C1ADB0DE6FF7

P577

Q38208794-70B73EFA-EFBF-46EB-9B17-3EE8E6D5F8CE

P698

Q38208794-C040A76A-766F-4C3A-BF74-111E1E8F00E3

P921

Q38208794-155081D2-1C6C-4482-8AE4-10AC113F725D

P932

Q38208794-FA1BEF68-E518-45DB-93ED-D443BC349D6D

P356

P1433

Clinical and Vaccine Immunology

P1476

Antibodies for treatment of Clostridium difficile infection.

@en

P2093

David P Humphreys

http://www.w3.org/2001/XMLSchema#string

P2860

Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile

Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain

Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile

In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B

Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.

Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.

Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

P304

913-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00116-14

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24789799

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

4097441

http://www.w3.org/2001/XMLSchema#string